Alnylam Pharmaceuticals, Inc. Message Board

Alnylam Pharmaceuticals Inc (Nasdaq:ALNY) is trading up 34%, increasing $4.30 to $16.82, after announcing its achievement of positive clinical results from its Phase I Trial with ALN-TTRo2.

To read the full report, follow the link below.
http://www.thestreetbeat.com/street-beat-articles-29/post-4838-alnylam-pharmaceuticals-nasdaq-alny-jumps-34-on-drug-study.aspx